Botulinum Toxin A (Botox, Dysport, Xeomin) Market: Patent Expiry Challenges And Strategic AdjustmentsReport

Botulinum Toxin A (Botox, Dysport, Xeomin) Market: Patent Expiry Challenges And Strategic Adjustments

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Botulinum Toxin A (Botox, Dysport, Xeomin) Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. Botulinum Toxin A (Botox, Dysport, Xeomin) Market: Indication Business Analysis
                    4.1. Indication Market Share, 2024 & 2033
                    4.2. Indication Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Million)
                    4.4. Chronic Migraine
                        4.4.1. Chronic Migraine Market, 2021 - 2033 (USD Million)
                    4.5. Spasticity (post-stroke or upper/lower limb spasticity)
                        4.5.1. Spasticity (post-stroke or upper/lower limb spasticity) Market, 2021 - 2033 (USD Million)
                    4.6. Hyperhidrosis (Excessive Sweating)
                        4.6.1. Hyperhidrosis (Excessive Sweating) Market, 2021 - 2033 (USD Million)
                    4.7. Cervical Dystonia (Spasmodic Torticollis)
                        4.7.1. Cervical Dystonia (Spasmodic Torticollis) Market, 2021 - 2033 (USD Million)
                    4.8. Overactive Bladder / Urinary Incontinence
                        4.8.1. Overactive Bladder / Urinary Incontinence Market, 2021 - 2033 (USD Million)
Chapter 5. Botulinum Toxin A (Botox, Dysport, Xeomin) Market: Regional Estimates & Trend Analysis
                    5.1. Regional Market Share Analysis, 2024 & 2033
                    5.2. Regional Market Dashboard
                    5.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
                    5.4. North America
                    5.5. Europe
                    5.6. Asia Pacific
                    5.7. Latin America
                    5.8. Middle East and Africa
Chapter 6. Competitive Landscape
                    6.1. Company Profile
                        6.1.1. Allergan
                            6.1.1.1. Overview
                            6.1.1.2. Financial Performance
                            6.1.1.3. Product Benchmarking
                            6.1.1.4. Strategic Mapping
                        6.1.2. Ipsen
                            6.1.2.1. Overview
                            6.1.2.2. Financial Performance
                            6.1.2.3. Product Benchmarking
                            6.1.2.4. Strategic Mapping
                        6.1.3. Merz Pharmaceuticals
                            6.1.3.1. Overview
                            6.1.3.2. Financial Performance
                            6.1.3.3. Product Benchmarking
                            6.1.3.4. Strategic Mapping
                        6.1.4. Revance Therapeutics
                            6.1.4.1. Overview
                            6.1.4.2. Financial Performance
                            6.1.4.3. Product Benchmarking
                            6.1.4.4. Strategic Mapping
                        6.1.5. Hugel, Inc.
                            6.1.5.1. Overview
                            6.1.5.2. Financial Performance
                            6.1.5.3. Product Benchmarking
                            6.1.5.4. Strategic Mapping 


List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Botulinum Toxin A (Botox, Dysport, Xeomin) market, by region, 2021 - 2033 (USD Million)
Table 4 North America Botulinum Toxin A (Botox, Dysport, Xeomin) market, by Indication, 2021 - 2033 (USD Million)
Table 5 Europe Botulinum Toxin A (Botox, Dysport, Xeomin) market, by Indication, 2021 - 2033 (USD Million)
Table 6 Asia Pacific Botulinum Toxin A (Botox, Dysport, Xeomin) market, by Indication, 2021 - 2033 (USD Million)
Table 7 Latin America Botulinum Toxin A (Botox, Dysport, Xeomin) market, by Indication, 2021 - 2033 (USD Million)
Table 8 Middle East & Africa Botulinum Toxin A (Botox, Dysport, Xeomin) market, by Indication, 2021 - 2033 (USD Million)


List of Figures

Fig. 1 Botulinum Toxin A (Botox, Dysport, Xeomin) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Botulinum Toxin A (Botox, Dysport, Xeomin) market dynamics
Fig. 12 Botulinum Toxin A (Botox, Dysport, Xeomin) market: Porter’s five forces analysis
Fig. 13 Botulinum Toxin A (Botox, Dysport, Xeomin) market: PESTLE analysis
Fig. 14 Indication market, 2021 - 2033 (USD Million)
Fig. 15 Botulinum Toxin A (Botox, Dysport, Xeomin) market revenue, by region
Fig. 16 Regional marketplace: Key takeaways
Fig. 17 North America Botulinum Toxin A (Botox, Dysport, Xeomin) market, 2021 - 2033 (USD Million)
Fig. 18 Europe Botulinum Toxin A (Botox, Dysport, Xeomin) market, 2021 - 2033 (USD Million)
Fig. 19 Asia Pacific Botulinum Toxin A (Botox, Dysport, Xeomin) market, 2021 - 2033 (USD Million)
Fig. 20 Latin America Botulinum Toxin A (Botox, Dysport, Xeomin) market, 2021 - 2033 (USD Million)
Fig. 21 MEA Botulinum Toxin A (Botox, Dysport, Xeomin) market, 2021 - 2033 (USD Million)
Fig. 22 Company categorization
Fig. 23 Company market position analysis
Fig. 24 Strategic framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo